Cargando…
Rheumatoid Arthritis and Malignancy: What Should We Do With DMARDs?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean College of Rheumatology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351408/ https://www.ncbi.nlm.nih.gov/pubmed/37476429 http://dx.doi.org/10.4078/jrd.22.0034 |
| _version_ | 1785074332769189888 |
|---|---|
| author | Jeon, Chan Hong |
| author_facet | Jeon, Chan Hong |
| author_sort | Jeon, Chan Hong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10351408 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Korean College of Rheumatology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103514082023-07-20 Rheumatoid Arthritis and Malignancy: What Should We Do With DMARDs? Jeon, Chan Hong J Rheum Dis Editorial Korean College of Rheumatology 2022-10-01 2022-09-13 /pmc/articles/PMC10351408/ /pubmed/37476429 http://dx.doi.org/10.4078/jrd.22.0034 Text en Copyright © 2022 by The Korean College of Rheumatology. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Jeon, Chan Hong Rheumatoid Arthritis and Malignancy: What Should We Do With DMARDs? |
| title | Rheumatoid Arthritis and Malignancy: What Should We Do With DMARDs? |
| title_full | Rheumatoid Arthritis and Malignancy: What Should We Do With DMARDs? |
| title_fullStr | Rheumatoid Arthritis and Malignancy: What Should We Do With DMARDs? |
| title_full_unstemmed | Rheumatoid Arthritis and Malignancy: What Should We Do With DMARDs? |
| title_short | Rheumatoid Arthritis and Malignancy: What Should We Do With DMARDs? |
| title_sort | rheumatoid arthritis and malignancy: what should we do with dmards? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351408/ https://www.ncbi.nlm.nih.gov/pubmed/37476429 http://dx.doi.org/10.4078/jrd.22.0034 |
| work_keys_str_mv | AT jeonchanhong rheumatoidarthritisandmalignancywhatshouldwedowithdmards |